Enveda

Series-B+
enveda.com Biotech & Healthcare Boulder, United States Founded 2019 251-500
Total Funding $714M
Latest Round $311M Series-B+
Last Announced Sep 23, 2026
Investors 22 Backers
Decision Makers 2 Verified

About Enveda

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Boulder, United States
Year Founded 2019
Team Size 251-500
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website enveda.com
Domain Registered Date Jul 13, 2001

Social & Network Presence

X / Twitter Profile @enveda (2.5K followers) Created on Dec 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

8 Events
  1. Capital Raise

    Raised $311,000,000 · Series-B+

    fiercebiotech.com

  2. Capital Raise

    Raised $150,000,000 · Series-B+

  3. Capital Raise

    Raised $130,000,000 · Series-B+

  4. Capital Raise

    Raised $55,000,000 · Series-B+

  5. Capital Raise

    Raised $68,000,000 · Series-B+

  6. Milestone

    X account created (@enveda)

    2.5K followers

  7. Milestone

    Company founded

    Boulder, United States

  8. Milestone

    Website domain registered

    enveda.com

Investors & Backers

22
Baillie Gifford
Catalio
Digitalis Ventures
Dimension
FPV Ventures
Hummingbird VC
ICONIQ
Jazz Venture Partners
Kinnevik
Level Ventures
Lifeforce Capital
Lightspeed
Lingotto
Lux Capital
Microsoft
Possible Ventures
Premji Invest
T. Rowe Price
The Nature Conservancy
True Ventures
Two Sigma Ventures
Wireframe Ventures

Funding History

5 Rounds
Series-B+ · Sep 23, 2026

Valuation: $2,000,000,000

$311,000,000 fiercebiotech.com
Series-B+ · Sep 4, 2025
$150,000,000 Source
Series-B+ · Nov 21, 2024
$130,000,000 Source
Series-B+ · Jun 14, 2024
$55,000,000 Source
Series-B+ · Dec 21, 2022
$68,000,000 Source

Founders & Leadership

8

Alex Mok

VP, Portfolio Strategy & Ops

Work email & phone locked Unlock →

August Allen

Chief Platform Officer

Work email & phone locked Unlock →

Diane Heiser

VP of Translational Medicine

Work email & phone locked Unlock →

Inhwan Kim

Chief Strategy Officer

Work email & phone locked Unlock →

Joe Davison

Senior Machine Learning Scientist

Work email & phone locked Unlock →

Robert Buckley

Chief People Officer

Work email & phone locked Unlock →

Vanitha Sekar

Chief Business Officer

Work email & phone locked Unlock →

Viswa Colluru

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts